CN Patent

CN114686548A — 用于增强生产的rna相关酶的修饰

Assigned to Translate Bio Inc · Expires 2022-07-01 · 4y expired

What this patent protects

本发明尤其提供了使用SUMO‑鸟苷酰转移酶融合蛋白用于大规模生产加帽的mRNA的方法和组合物。

USPTO Abstract

本发明尤其提供了使用SUMO‑鸟苷酰转移酶融合蛋白用于大规模生产加帽的mRNA的方法和组合物。

Drugs covered by this patent

vutrisiran-sodium (VUTRISIRAN SODIUM)

Patent Metadata

Patent number: CN114686548A
Jurisdiction: CN
Classification: —
Expires: 2022-07-01
Drug substance claim: No
Drug product claim: No
Assignee: Translate Bio Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.